PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues - Concepedia

Concepedia

Publication | Open Access

PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues

DOI Full Paper Access

19

Citations

35

References

2012

Year

Simone Däpp, Cristina Müller, Elisa Garcı́a Garayoa, Peter Bläuenstein, Véronique Maes, Luc Brans, Dirk Tourwé, Roger Schibli

EJNMMI Research

References

	Year	Citations

Page 1